DAX 25.016 -1,8%ESt50 6.223 -1,5%MSCI World 4.843 -0,4%Top 10 Crypto 8,11 -3,6%Nas 25.819 -1,2%Bitcoin 54.432 -2,0%Euro 1,1398 -0,1%Öl 78,0 +2,7%Gold 4.073 -0,8%
Beliebte Suche
DAX 40ÖlpreisEuro - DollarBitcoin - EuroGoldpreis
Meistgesucht
BioNTech (ADRs)A2PSR2TeslaA1CX3TAmazon906866NEL ASAA0B733Microsoft870747Apple865985Siemens EnergyENER6YBASFBASF11NVIDIA918422Lufthansa823212Mercedes-Benz Group (ex Daimler)710000BayerBAY001Daimler TruckDTR0CKPlug PowerA1JA81TUITUAG00
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero.Hier informieren
Top News
Suche...
Jetzt kostenlos
bei finanzen.net anmelden
Watchlists & MusterdepotsTools & integriertes TradingNewsletter, Trading-Desk uvm.
Schon einen Account? Anmelden

EQS-News: thyssenkrupp nucera recorded strong sales growth and slightly better-than-expected earnings in Q4 and FY 2023/24; project execution well on track

Werte in diesem Artikel
Aktien
thyssenkrupp nucera AG & Co. KGaA
7.50 EUR -0.13 EUR -1.70 %
Charts | News | Analysen
Aktie kaufen

EQS-News: thyssenkrupp nucera AG & Co. KGaA / Key word(s): Preliminary Results
thyssenkrupp nucera recorded strong sales growth and slightly better-than-expected earnings in Q4 and FY 2023/24; project execution well on track

18.11.2024 / 18:01 CET/CEST
The issuer is solely responsible for the content of this announcement.

Werbung

TRADING STATEMENT: thyssenkrupp nucera recorded strong sales growth and slightly better-than-expected earnings in Q4 and FY 2023/24; project execution well on track

Q4 2023/24: Strong performance in the last quarter with positive order intake momentum, strongly growing alkaline water electrolysis (AWE) sales and resilient profitability
  • Growing order intake driven by Chlor-Alkali (CA) service business; AWE order intake on prior year’s level
  • Strong year-on-year sales growth due to AWE business; AWE sales doubled in Q4 and thereby reached a new all-time high, reflecting significant progress of projects under execution; CA sales roughly on par with previous year
  • EBIT below prior year, but slightly better than expected; EBIT decline due to planned ramp-up costs and lower gross margin in line with higher AWE sales share, partly offset by strong margins in CA business and cost containment

FY 2023/24:
  • Order intake slightly above prior year’s level, largely driven by the AWE project with Stegra (H2 Green Steel) in Sweden; CA order intake fell from the previous year’s record high, which was supported by the large OxyChem project in the US
  • Group sales guidance of 820mn € to 900mn € reached as well as AWE sales target of 500mn € to 550mn €; both sales figures came in roughly in the middle of the range
    • Strong sales increase mostly driven by the dynamic sales growth in the AWE business following ongoing execution of projects, especially in Saudi Arabia and Sweden
    • CA sales slightly above prior year’s level
  • EBIT slightly better than originally expected (guidance: negative EBIT figure in mid double-digit mn € range)
    • Significant year-on-year EBIT decline mainly due to the planned organizational ramp-up and AWE capacity build-up, higher R&D expenditures as well as the increased share of AWE sales, which is currently still accompanied by lower gross margins
    • Successful CA business delivered healthy profit margins and thereby supported the expansion towards green hydrogen

All statements reported herein are preliminary and unaudited. Full financial disclosure for Q4/FY 2023/24 will be published as planned on 17 December 2024 at 07:00 am CET.
 

18.11.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: thyssenkrupp nucera AG & Co. KGaA
Freie-Vogel-Str. 385 a
44269 Dortmund
Germany
Phone: +49 231-22972-7100
E-mail: info@thyssenkrupp-nucera.com
Internet: www.thyssenkrupp-nucera.com
ISIN: DE000NCA0001
WKN: NCA000
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2032301

 
End of News EQS News Service
Werbung

2032301  18.11.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2032301&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Aktuelle thyssenkrupp nucera Aktie News

Werbung

thyssenkrupp nucera Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für thyssenkrupp nucera nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
30.06.26 thyssenkrupp nucera Neutral Goldman Sachs Group Inc.
11.05.26 thyssenkrupp nucera Outperform RBC Capital Markets
20.03.26 thyssenkrupp nucera Neutral Goldman Sachs Group Inc.
19.03.26 thyssenkrupp nucera Buy Deutsche Bank AG
18.03.26 thyssenkrupp nucera Buy Deutsche Bank AG